Beste Plenary Session podcaster (2024)

"Masking Mistakes: Lessons from the Science, Policy, and Coverage of COVID-19", the 2024 Brian Shields Lecture on Institutional Ethics which took place on Monday, October 7, 2024 for the Emory Center for Ethics. A conversation with Carlos Del Rio, MD and Vinay Prasad, MD MPH with moderation by Gerard Vong, DPhil, Director of the MA in Bioethics pro…

1
How We Can Do Better As A County Hospital 41:34

Play Pause

2M ago41:34

41:34

Screening/ Drug efficacy/ Sotorasib/ Adaura and moreAv Plenary Session

1
Driver mutation lung cancer - My lecture 37:22

3M ago37:22

37:22

My UCSF lecture on driver mutation lung cancerAv Plenary Session

1
Post ASCO wrap up with Timothee Olivier 45:27

4M ago45:27

45:27

We break down the best studies from ASCOAv Plenary Session

1
Critical Appraisal - My 2 hour ASCO lecture - Day 2 version 1:54:09

5M ago1:54:09

1:54:09

Critical Appraisal - My 2 hour ASCO lecture - Day 2 version by Plenary SessionAv Plenary Session

1
Asco Prequel - We talk about what to look for 29:34

5M ago29:34

29:34

What you need to know in advance of ASCOAv Plenary Session

1
A SM crossover - Cifu, Prasad, Mandrola 45:22

5M ago45:22

45:22

Should trials have carbon footprint as an endpoint?Av Plenary Session

1
When Evidence EXPIRES - My Grand Rounds Today at Mt Sinai 52:42

6M ago52:42

52:42

My grand rounds; Beta blockers post MISingle center vs multicenter RCTMasksBoosters and moreAv Plenary Session

1
Cifu, Mandrola, Prasad - SM crossover 41:50

6M ago41:50

41:50

I crossover SM podcast; Harvard med students video, Justice curriculum, Masking half the yearAv Plenary Session

1
Patient advocates funded by Pharma 26:14

7M ago26:14

26:14

Patient advocates, Pharma funding, and is MRD a suitable endpointAv Plenary Session

1
FDA makes MRD the basis for AA 8:32

7M ago8:32

8:32

5 reasons that is a bad ideaAv Plenary Session

1
Beta Blockers After Heart Attacks Don't Work 15:33

7M ago15:33

15:33

Another flawed quality metric. Reviewing the NEJM paper "Beta-Blockers After Myocardial Infarction and Preserved Ejection Fraction".Av Plenary Session